Compared to Estimates, Celanese (CE) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2025, Celanese (CE) reported revenue of $2.53 billion, down 4.5% over the same period last year. EPS came in at $1.44, compared to $2.38 in the year-ago quarter.
The reported revenue represents a surprise of +1.42% over the Zacks Consensus Estimate of $2.5 billion. With the consensus EPS estimate being $1.38, the EPS surprise was +4.35%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Celanese performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:- Net Sales- Acetyl Chain: $1.12 billion versus the four-analyst average estimate of $1.1 billion. The reported number represents a year-over-year change of -7.2%.
- Net Sales- Inter segment eliminations: $-25 million versus $-20.32 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +38.9% change.
- Net Sales- Engineered Materials: $1.44 billion versus the four-analyst average estimate of $1.35 billion. The reported number represents a year-over-year change of -1.7%.
- Operating EBITDA- Acetyl Chain: $260 million compared to the $287.13 million average estimate based on four analysts.
- Operating EBITDA- Other Activities: $-54 million compared to the $-56.51 million average estimate based on four analysts.
- Operating EBITDA- Engineered Materials: $326 million compared to the $278.5 million average estimate based on four analysts.
View all Key Company Metrics for Celanese here>>>
Shares of Celanese have returned -21.3% over the past month versus the Zacks S&P 500 composite's +2.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Celanese Corporation (CE): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Source Zacks-com
